This site is intended for Healthcare Professionals only

overactive bladder

white tablet summary.jpg

MHRA rejects POM to P switch for oxybutynin medicine

Evidence shows medical supervision is still required to ensure safe use of Aquiette, says MHRA

15 May 2023 , 1 Min Article

overactive bladder, summary.jpg

Mixed reaction to proposed oxybutynin POM to P switch

Some pharmacists have criticised a proposal to reclassify the drug for overactive bladder in women.

25 Apr 2022 , 2 Min Article

Change privacy settings